TP53 and cancer: In HPV-induced cancers, the Wnt signaling is activated by HPV E6 and E7 oncoproteins through inhibiting various regulatory factors such as p53, human telomerase reverse transcriptase (hTERT), and protein phosphatase 2A (PP2A) [94].